Suppression of the neoplastic phenotype by transfection of phospholipase C β 3 to neuroendocrine tumor cells
Peter Stålberg(Uppsala University Hospital), Britt Skogseid(Uppsala University), Shu Wang(Shanghai Jiao Tong University), Günther Weber(Goethe University Frankfurt), Catharina Larsson(Karolinska University Hospital), Kjell Öberg(Uppsala University Hospital), Anders Gobl(Uppsala University Hospital)
Cited by 9
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
|Neuroendocrinology|2012|869
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863